Vertex Pharmaceuticals Incorporated
Pteridinone compounds and uses thereof
Last updated:
Abstract:
The present invention provides compounds of Formula I, or pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods of use thereof for treating cellular proliferative disorders (e.g., cancer).
Status:
Grant
Type:
Utility
Filling date:
23 Apr 2019
Issue date:
13 Jul 2021